DKK 4.44
(1.14%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 89.51 Million DKK | 103.72% |
2022 | 43.93 Million DKK | 113.98% |
2021 | 20.53 Million DKK | 68.58% |
2020 | 12.18 Million DKK | 95.49% |
2019 | 6.23 Million DKK | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 86.9 Million DKK | -2.91% |
2024 Q2 | 86.9 Million DKK | 0.0% |
2023 FY | 89.51 Million DKK | 103.72% |
2023 Q4 | 89.51 Million DKK | 0.0% |
2023 Q3 | 89.51 Million DKK | 78.41% |
2023 Q2 | 50.17 Million DKK | 0.0% |
2023 Q1 | 50.17 Million DKK | 14.19% |
2022 Q3 | 40.33 Million DKK | 18.98% |
2022 Q2 | 33.89 Million DKK | 0.0% |
2022 Q1 | 33.89 Million DKK | 65.08% |
2022 Q4 | 43.93 Million DKK | 8.95% |
2022 FY | 43.93 Million DKK | 113.98% |
2021 Q4 | 20.53 Million DKK | 0.0% |
2021 FY | 20.53 Million DKK | 68.58% |
2021 Q3 | 20.53 Million DKK | 0.0% |
2021 Q2 | - DKK | 0.0% |
2021 Q1 | - DKK | 0.0% |
2020 FY | 12.18 Million DKK | 95.49% |
2019 FY | 6.23 Million DKK | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ambu A/S | 1.46 Billion DKK | 93.894% |
ChemoMetec A/S | 111.35 Million DKK | 19.616% |
Demant A/S | 21.2 Billion DKK | 99.578% |
GN Store Nord A/S | 21.05 Billion DKK | 99.575% |
ViroGates A/S | 7.54 Million DKK | -1085.915% |